These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 23932463

  • 21. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
    Rhee MY, Baek SH, Kim W, Park CG, Park SW, Oh BH, Kim SH, Kim JJ, Shin JH, Yoo BS, Rim SJ, Ha JW, Doh JH, Ahn Y, Chae JK, Park JB, Kim SK, Kim CH.
    Drug Des Devel Ther; 2015; 9():2847-54. PubMed ID: 26082615
    [Abstract] [Full Text] [Related]

  • 22. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD, Iberian Multicenter Imidapril Study on Hypertension.
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [Abstract] [Full Text] [Related]

  • 23. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
    Smith DH, Dubiel R, Jones M.
    Am J Cardiovasc Drugs; 2005 Dec; 5(1):41-50. PubMed ID: 15631537
    [Abstract] [Full Text] [Related]

  • 24. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 25. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
    Palatini P, Malacco E, Di SS, Carretta R, Dorigatti F, Bertocchi F, Mann J.
    Eur J Clin Pharmacol; 2002 Jan; 57(11):765-70. PubMed ID: 11868797
    [Abstract] [Full Text] [Related]

  • 26. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.
    Malacco E, Santonastaso M, Varì NA, Gargiulo A, Spagnuolo V, Bertocchi F, Palatini P, Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril Study.
    Clin Ther; 2004 Jun; 26(6):855-65. PubMed ID: 15262456
    [Abstract] [Full Text] [Related]

  • 27. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim KI, Shin MS, Ihm SH, Youn HJ, Sung KC, Chae SC, Nam CW, Seo HS, Park SM, Rhee MY, Kim MH, Cha KS, Kim YJ, Kim JJ, Chun KJ, Yoo BS, Park S, Shin ES, Kim DS, Il Kim D, Kim KH, Joo SJ, Jeong JO, Shin J, Kim CH.
    Clin Ther; 2016 Oct; 38(10):2159-2170. PubMed ID: 27502326
    [Abstract] [Full Text] [Related]

  • 28. Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
    Coca A, Calvo C, Sobrino J, Gómez E, López-Paz JE, Sierra C, Bragulat E, de la Sierra A.
    Clin Ther; 2003 Nov; 25(11):2849-64. PubMed ID: 14693309
    [Abstract] [Full Text] [Related]

  • 29. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF.
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [Abstract] [Full Text] [Related]

  • 30. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
    Lee HY, Hong BK, Chung WJ, Lee BK, Lee SH, Jeon DW, Ahn YK, Kim D, Park CK, Kim SH, Jung HO, Kim BO, Choi D.
    Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
    [Abstract] [Full Text] [Related]

  • 31. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH, Lee HY, Hong Baek S, Jeon HK, Kang JH, Kim YN, Park CG, Ryu JK, Rhee MY, Kim MH, Hong TJ, Choi DJ, Cho SW, Cha DH, Jeon ES, Kim JJ, Shin JH, Park SH, Lee SH, John SH, Shin ES, Kim NH, Lee SY, Kwan J, Jeong MH, Kim SW, Jeong JO, Kim DW, Lee NH, Park WJ, Ahn JC, Won KH, Uk Lee S, Cho JH, Kim SK, Ahn T, Hong S, Yoo SY, Kim SY, Kim BS, Juhn JH, Kim SY, Lee YJ, Oh BH.
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [Abstract] [Full Text] [Related]

  • 33. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB, Lacourciere Y, Davidai G.
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators.
    Lancet; 2014 May 31; 383(9932):1889-98. PubMed ID: 24881993
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial.
    Shin DH, Song S, Lee YB.
    Cardiovasc Ther; 2019 May 31; 2019():7836527. PubMed ID: 31772615
    [Abstract] [Full Text] [Related]

  • 36. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.
    Blood Press Monit; 2004 Aug 31; 9(4):203-10. PubMed ID: 15311147
    [Abstract] [Full Text] [Related]

  • 37. Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.
    Elliott WJ, Calhoun DA, DeLucca PT, Gazdick LP, Kerns DE, Zeldin RK.
    Clin Ther; 2001 Aug 31; 23(8):1166-79. PubMed ID: 11558856
    [Abstract] [Full Text] [Related]

  • 38. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P, Malacco E, Fogari R, Carretta R, Bonaduce D, Bertocchi F, Mann J, Condorelli M, Italian Collaborative Study Group.
    J Hypertens; 2001 Sep 31; 19(9):1691-6. PubMed ID: 11564991
    [Abstract] [Full Text] [Related]

  • 39. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker.
    Pool JL, Glazer R, Chiang YT, Gatlin M.
    J Hum Hypertens; 1999 Apr 31; 13(4):275-81. PubMed ID: 10333347
    [Abstract] [Full Text] [Related]

  • 40. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours.
    Neutel J, Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M.
    Clin Ther; 1997 Apr 31; 19(3):447-58; discussion 367-8. PubMed ID: 9220209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.